Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02078648
Title Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Stemline Therapeutics, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama Birmingham Alabama 35294 United States Details
Barrow Neurological Institute Phoenix Arizona 85013 United States Details
Center for Neurosciences Tucson Arizona 85718 United States Details
Cedars Sinai Medical Center Los Angeles California 90048 United States Details
George Washington University Washington District of Columbia 20052 United States Details
University of Florida Gainesville Florida 32611 United States Details
Piedmont Cancer Institute Atlanta Georgia 30309 United States Details
Northwestern University Chicago Illinois 60208 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02115 United States Details
Henry Ford Health System Detroit Michigan 48202 United States Details
Columbia University Medical Center New York New York 10027 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15260 United States Details
Rhode Island Hospital Providence Rhode Island 02903 United States Details
Baylor Charles A Sammons Cancer Center Dallas Texas 75246 United States Details
University of Virginia Charlottesville Virginia 22908 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field